BioPlx Overview
- Year Founded
-
2015

- Status
-
Private
- Latest Deal Type
-
Debt - PPP
- Latest Deal Amount
-
$187K
BioPlx General Information
Description
Operator of a microbiome research analysis company intended to develop non-antibiotic treatments for infectious diseases. The company specializes in the research and development of targeted microbiological agents that facilitate the creation of interventional formulations, providing medical practitioners with clinically effective microbiome agents to prevent recurring staph infections.
Contact Information
Website
www.bioplx.comCorporate Office
- 1800 30th Street
- Suite 213
- Boulder, CO 80301
- United States
Corporate Office
- 1800 30th Street
- Suite 213
- Boulder, CO 80301
- United States
BioPlx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Debt - PPP | 27-Apr-2020 | $187K | Completed | Generating Revenue | ||
2. Seed Round | 24-Feb-2020 | Completed | Generating Revenue | |||
1. Seed Round | 16-Aug-2019 | $1.64M | $1.64M | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
BioPlx Comparisons
Industry
Financing
Details
BioPlx Competitors (1)
One of BioPlx’s competitors is Second Genome, a Formerly VC-backed company based in Brisbane, CA.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Second Genome | Formerly VC-backed | Brisbane, CA |
BioPlx Patents
BioPlx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4158010-A1 | Methods for stable genomic integration in recombinant microorganisms | Pending | 02-Jun-2020 | ||
CA-3181274-A1 | Methods for stable genomic integration in recombinant microorganisms | Pending | 02-Jun-2020 | ||
EP-4158010-A4 | Methods for stable genomic integration in recombinant microorganisms | Pending | 02-Jun-2020 | ||
CA-3146363-A1 | Live biotherapeutic compositions and methods | Pending | 08-Jul-2019 | ||
AU-2020309551-A1 | Live biotherapeutic compositions and methods | Inactive | 08-Jul-2019 | A61K35/74 |
BioPlx FAQs
-
When was BioPlx founded?
BioPlx was founded in 2015.
-
Where is BioPlx headquartered?
BioPlx is headquartered in Boulder, CO.
-
What industry is BioPlx in?
BioPlx’s primary industry is Drug Discovery.
-
Is BioPlx a private or public company?
BioPlx is a Private company.
-
What is BioPlx’s current revenue?
The current revenue for BioPlx is
. -
How much funding has BioPlx raised over time?
BioPlx has raised $2.72M.
-
Who are BioPlx’s competitors?
Second Genome is a competitor of BioPlx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »